ADMA Biologics Inc — datos financieros trimestrales (NASDAQ:ADMA) | MetaTrader

Ver el calendario completo

Financials

Visión general Informes Estadísticas

Flujo de caja de las actividades operativas 50.22 M-19.68 M21.14 M13.29 M35.64 M 50.4 M Flujo de caja de las actividades de inversión -2.75 M-4.72 M-2.53 M-14.37 M-276 K -21.89 M Flujo de caja de las actividades financieras -31.03 M-7.13 M48 K-27.82 M-9.12 M -44.02 M Flujo de caja libre 47.47 M-24.39 M18.61 M-1.07 M34.36 M 27.5 M

Noticias

Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider

ADMA Crashes 42.5% YTD: Right Time to Buy the Stock?

TVTX Stock Soars on FDA Nod for Filspari in Second Kidney Indication

NVO Inks Deal With OpenAI for Speedy Drug Discovery Globally, Stock Up

Replimune Gets Second FDA CRL for Melanoma Drug BLA, Stock Crashes

Is ADMA Poised for Margin Growth and Supply Expansion in 2026?

Adma Biologics (ADMA) Laps the Stock Market: Here's Why

ADMA Biologics: The Short Report Is The Noise, Not The Signal (NASDAQ:ADMA)

Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?

NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up

Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio

Incyte Reports Strong 54-Week Data From Late-Stage Skin Disorder Study